MedTrace Logo

Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance

NCT03743610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2024-02-20

No results posted yet for this study

Summary

The investigators expect to find that different intensity and altitude exposure levels will show what kind of intermittent exposure protocol is more beneficial to athletes and healthy individuals that experience acute exposure to altitude during exercise. This may furthermore be related to acute altitude exposure for recreational exercise use as well.

Conditions

  • Altitude Hypoxia

Interventions

OTHER

Simulated altitude

Participants will exercise in simulated altitude will range between 2100 feet and 16400 feet and will increase according to arm guidelines

OTHER

Placebo simulated altitude

Participants will exercise at sea level at similar percentage of intensities to the simulated altitude group.

Sponsors & Collaborators

Principal Investigators

  • Courtney M Wheatley · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-10-19
Completion
2023-10-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743610 on ClinicalTrials.gov